[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Mila Joy [@MilaLovesJoe](/creator/twitter/MilaLovesJoe) on x 349.2K followers Created: 2025-07-17 07:17:30 UTC BREAKING NEWS: Senator Rand Paul faces scrutiny over possible insider trading Kentucky Senator Rand Paul is under fire after disclosing—16 months late—that his wife, Kelley Paul, purchased up to $XXXXXX in Gilead Sciences stock on February 26, 2020, the maker of COVID-19 treatment remdesivir. The Stop Trading on Congressional Knowledge (STOCK) Act requires such disclosures within XX days, raising concerns about potential insider trading. The transaction, made shortly after congressional briefings on the looming pandemic, has sparked calls for a Senate Ethics Committee investigation. Paul’s team claims the delay was due to a filing error and that the investment lost money. No SEC charges have been filed, but critics demand answers. More details to follow as the story develops.  XXXXX engagements  **Related Topics** [insider](/topic/insider) [breaking news](/topic/breaking-news) [gilead sciences](/topic/gilead-sciences) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/MilaLovesJoe/status/1945744653158133973)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Mila Joy @MilaLovesJoe on x 349.2K followers
Created: 2025-07-17 07:17:30 UTC
BREAKING NEWS:
Senator Rand Paul faces scrutiny over possible insider trading
Kentucky Senator Rand Paul is under fire after disclosing—16 months late—that his wife, Kelley Paul, purchased up to $XXXXXX in Gilead Sciences stock on February 26, 2020, the maker of COVID-19 treatment remdesivir.
The Stop Trading on Congressional Knowledge (STOCK) Act requires such disclosures within XX days, raising concerns about potential insider trading.
The transaction, made shortly after congressional briefings on the looming pandemic, has sparked calls for a Senate Ethics Committee investigation.
Paul’s team claims the delay was due to a filing error and that the investment lost money.
No SEC charges have been filed, but critics demand answers.
More details to follow as the story develops.
XXXXX engagements
Related Topics insider breaking news gilead sciences stocks healthcare
/post/tweet::1945744653158133973